| http://www.w3.org/ns/prov#value | - In Federal Trade Commission v. Watson Pharmaceuticals, Inc., the Supreme Court will address: whether reverse-payment agreements are per se lawful unless the underlying patent litigation was a sham or the patent was obtained by fraud (as the Eleventh Circuit held), or instead are presumptively anticompetitive and unlawful (as the Third Circuit held).
|
